Cellosaurus logo
expasy logo

Cellosaurus Jurkat (CVCL_0065)

[Text version]
Cell line name Jurkat
Synonyms JURKAT; JM; JM-Jurkat; Jurkat-FHCRC; Jurkat FHCRC; FHCRC-11; FHCRC subclone 11; FCCH1024
Accession CVCL_0065
Resource Identification Initiative To cite this cell line use: Jurkat (RRID:CVCL_0065)
Comments Group: Space-flown cell line (cellonaut).
Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
Part of: COSMIC cell lines project.
Part of: ENCODE project common cell types; tier 3.
Part of: International Histocompatibility Workshop cell lines.
Part of: LL-100 blood cancer cell line panel.
Population: Caucasian.
Doubling time: 26 hours (PubMed=17117183); ~25-35 hours (DSMZ=ACC-282).
Microsatellite instability: Instable (MSI-high) (PubMed=10739008; PubMed=11226526; PubMed=31068700; Sanger).
Omics: Acetylation analysis by proteomics.
Omics: Deep exome analysis.
Omics: DNA methylation analysis.
Omics: Deep phosphoproteome analysis.
Omics: Deep proteome analysis.
Omics: Deep quantitative proteome analysis.
Omics: HLA class I peptidome analysis by proteomics.
Omics: N-glycan profiling.
Omics: SNP array analysis.
Omics: Transcriptome analysis by microarray.
Omics: Transcriptome analysis by RNAseq.
Omics: Ubiquitination analysis by proteomics.
Omics: Virome analysis using proteomics.
Anecdotal: Have been flown in space on Cosmos-2044 to study the inhibition of phorbol ester-induced cell activation in microgravity (PubMed=1915666).
Misspelling: Jurcat; Note=Occasionally.
Misspelling: JURKET; PubMed=313568.
Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
Cell type: T-cell; CL=CL_0000084.
Sequence variations
  • Mutation; HGNC; 959; BAX; Simple; p.Glu41Argfs*19 (c.121delG); ClinVar=VCV000009512; Zygosity=Heterozygous (PubMed=9583678).
  • Mutation; HGNC; 959; BAX; Simple; p.Glu41Glyfs*33 (c.121dupG); ClinVar=VCV000009511; Zygosity=Heterozygous (PubMed=9583678).
  • Mutation; HGNC; 16712; FBXW7; Simple; p.Arg505Cys (c.1513C>T); ClinVar=VCV000069961; Zygosity=Heterozygous (PubMed=22675565; Cosmic-CLP=998184).
  • Mutation; HGNC; 6079; INPP5D; Simple; p.Gln345Ter (c.1033C>T); Zygosity=Heterozygous (PubMed=19473701).
  • Mutation; HGNC; 6079; INPP5D; Simple; c.1097+1065_1097+1112del47; Zygosity=Heterozygous (PubMed=19473701).
  • Mutation; HGNC; 7325; MSH2; Simple; p.Arg711Ter (c.2131C>T); ClinVar=VCV000090903; Zygosity=Homozygous (PubMed=9583678).
  • Mutation; HGNC; 7329; MSH6; Simple; p.Phe1088Serfs*2 (c.3261delC); ClinVar=VCV000089363; Zygosity=Homozygous (PubMed=9510473).
  • Mutation; HGNC; 7881; NOTCH1; Simple; p.Arg1627His (c.4880G>A); ClinVar=VCV000409067; Zygosity=Heterozygous (PubMed=15472075).
  • Mutation; HGNC; 11998; TP53; Simple; p.Arg196Ter (c.586C>T); ClinVar=VCV000043589; Zygosity=Heterozygous (PubMed=2144611; PubMed=10071127; PubMed=19220422; PubMed=22675565; Cosmic-CLP=998184).
HLA typing Source: DSMZCellDive=ACC-282
Class I
Class II
Genome ancestry Source: PubMed=30894373

Origin% genome
Native American0
East Asian, North0.13
East Asian, South1.21
South Asian1.08
European, North70.73
European, South26.45
Disease Childhood T acute lymphoblastic leukemia (NCIt: C7953)
Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_UQ00 (Abcam Jurkat ABI1 KO)CVCL_UQ01 (Abcam Jurkat ACAA1 KO)CVCL_UQ02 (Abcam Jurkat ACAT2 KO)
CVCL_UQ03 (Abcam Jurkat ACOT13 KO)CVCL_UQ04 (Abcam Jurkat ACTR3 KO)CVCL_UQ05 (Abcam Jurkat ACVR2B KO)
CVCL_UQ06 (Abcam Jurkat ACVRL1 KO)CVCL_UQ07 (Abcam Jurkat ACY1 KO)CVCL_UQ08 (Abcam Jurkat ADD1 KO)
CVCL_UQ09 (Abcam Jurkat AHCY KO)CVCL_UQ10 (Abcam Jurkat AKR7A2 KO)CVCL_UQ11 (Abcam Jurkat ALAD KO)
CVCL_UQ12 (Abcam Jurkat ALDH1A2 KO)CVCL_UQ13 (Abcam Jurkat ALDH4A1 KO)CVCL_UQ14 (Abcam Jurkat ALDOB KO)
CVCL_UQ15 (Abcam Jurkat ALOX5AP KO)CVCL_UQ16 (Abcam Jurkat ARSA KO)CVCL_UQ17 (Abcam Jurkat ASL KO)
CVCL_UQ18 (Abcam Jurkat ATXN2 KO)CVCL_UQ19 (Abcam Jurkat BAZ2A KO)CVCL_UQ20 (Abcam Jurkat BCAT1 KO)
CVCL_UQ21 (Abcam Jurkat BCAT2 KO)CVCL_UQ22 (Abcam Jurkat BRMS1 KO)CVCL_UQ23 (Abcam Jurkat BTLA KO)
CVCL_UQ24 (Abcam Jurkat CA8 KO)CVCL_UQ25 (Abcam Jurkat CALU KO)CVCL_UQ26 (Abcam Jurkat CAMK4 KO)
CVCL_UQ27 (Abcam Jurkat CASP10 KO)CVCL_UQ28 (Abcam Jurkat CASP2 KO)CVCL_UQ29 (Abcam Jurkat CBLC KO)
CVCL_UQ30 (Abcam Jurkat CCS KO)CVCL_B7V8 (Abcam Jurkat CD1A KO)CVCL_B0Z5 (Abcam Jurkat CD1C KO)
CVCL_B7V9 (Abcam Jurkat CD247 KO)CVCL_UQ31 (Abcam Jurkat CHP1 KO)CVCL_UQ32 (Abcam Jurkat CLASP1 KO)
CVCL_UQ33 (Abcam Jurkat CLPP KO)CVCL_UQ34 (Abcam Jurkat CMAS KO)CVCL_UQ35 (Abcam Jurkat CNDP2 KO)
CVCL_UQ36 (Abcam Jurkat CRYZ KO)CVCL_UQ37 (Abcam Jurkat CYB5A KO)CVCL_UQ38 (Abcam Jurkat CYB5R3 KO)
CVCL_UQ39 (Abcam Jurkat DFFB KO)CVCL_UQ40 (Abcam Jurkat DGAT1 KO)CVCL_UQ41 (Abcam Jurkat DGKA KO)
CVCL_UQ42 (Abcam Jurkat DNPEP KO)CVCL_UQ43 (Abcam Jurkat DNTT KO)CVCL_UQ44 (Abcam Jurkat DPP8 KO)
CVCL_UQ45 (Abcam Jurkat EPHX1 KO)CVCL_UQ46 (Abcam Jurkat EPHX2 KO)CVCL_UQ47 (Abcam Jurkat EPN1 KO)
CVCL_UQ48 (Abcam Jurkat ETV4 KO)CVCL_UQ49 (Abcam Jurkat FDX1 KO)CVCL_UQ50 (Abcam Jurkat FECH KO)
CVCL_UQ51 (Abcam Jurkat FOLR2 KO)CVCL_UQ52 (Abcam Jurkat FOSB KO)CVCL_UQ53 (Abcam Jurkat FPGS KO)
CVCL_UQ54 (Abcam Jurkat FRK KO)CVCL_UQ55 (Abcam Jurkat FUBP1 KO)CVCL_UQ56 (Abcam Jurkat GAMT KO)
CVCL_UQ57 (Abcam Jurkat GANAB KO)CVCL_UQ58 (Abcam Jurkat GART KO)CVCL_UQ59 (Abcam Jurkat GCDH KO)
CVCL_UQ60 (Abcam Jurkat GGH KO)CVCL_UQ61 (Abcam Jurkat GLG1 KO)CVCL_UQ62 (Abcam Jurkat GLUL KO)
CVCL_UQ63 (Abcam Jurkat GNE KO)CVCL_UQ64 (Abcam Jurkat GRK3 KO)CVCL_UQ65 (Abcam Jurkat GRK6 KO)
CVCL_UQ66 (Abcam Jurkat GUSB KO)CVCL_UQ67 (Abcam Jurkat HDAC10 KO)CVCL_UQ68 (Abcam Jurkat HDGF KO)
CVCL_UQ69 (Abcam Jurkat HEXA KO)CVCL_UQ70 (Abcam Jurkat HIF1AN KO)CVCL_D1LF (Abcam Jurkat HMBS KO)
CVCL_UQ71 (Abcam Jurkat HMGCS2 KO)CVCL_UQ72 (Abcam Jurkat HMOX2 KO)CVCL_UQ73 (Abcam Jurkat HSD17B10 KO)
CVCL_UQ74 (Abcam Jurkat HSD17B4 KO)CVCL_UQ75 (Abcam Jurkat HSPA13 KO)CVCL_UQ76 (Abcam Jurkat HSPA1L KO)
CVCL_UQ77 (Abcam Jurkat HSPA2 KO)CVCL_UQ78 (Abcam Jurkat HSPA4 KO)CVCL_UQ79 (Abcam Jurkat HSPH1 KO)
CVCL_B7VD (Abcam Jurkat IDH2 KO)CVCL_B0Z6 (Abcam Jurkat IFNG KO)CVCL_B0Z7 (Abcam Jurkat IKZF1 KO)
CVCL_UQ80 (Abcam Jurkat IKZF3 KO)CVCL_UQ81 (Abcam Jurkat IL13RA1 KO)CVCL_UQ82 (Abcam Jurkat IL2RG KO)
CVCL_UQ83 (Abcam Jurkat IMPDH1 KO)CVCL_UQ84 (Abcam Jurkat ITGA4 KO)CVCL_B7VA (Abcam Jurkat LCK KO)
CVCL_B7VB (Abcam Jurkat LEF1 KO)CVCL_UQ85 (Abcam Jurkat LGALS8 KO)CVCL_UQ86 (Abcam Jurkat LIAS KO)
CVCL_UQ87 (Abcam Jurkat LPXN KO)CVCL_UQ88 (Abcam Jurkat MAEA KO)CVCL_UQ89 (Abcam Jurkat MAP3K4 KO)
CVCL_UQ90 (Abcam Jurkat MAP4K1 KO)CVCL_UQ91 (Abcam Jurkat MAP4K4 KO)CVCL_UQ92 (Abcam Jurkat MARK3 KO)
CVCL_UQ93 (Abcam Jurkat MAT1A KO)CVCL_UQ94 (Abcam Jurkat ME2 KO)CVCL_UQ95 (Abcam Jurkat MMACHC KO)
CVCL_UQ96 (Abcam Jurkat MPG KO)CVCL_UQ97 (Abcam Jurkat MTHFR KO)CVCL_UQ98 (Abcam Jurkat NAGK KO)
CVCL_UQ99 (Abcam Jurkat NAPRT KO)CVCL_WQ00 (Abcam Jurkat NAT1 KO)CVCL_WQ01 (Abcam Jurkat NCOA5 KO)
CVCL_WQ02 (Abcam Jurkat NDUFA12 KO)CVCL_WQ03 (Abcam Jurkat NDUFAF2 KO)CVCL_WQ04 (Abcam Jurkat NDUFB6 KO)
CVCL_WQ05 (Abcam Jurkat NDUFB8 KO)CVCL_WQ06 (Abcam Jurkat NDUFS1 KO)CVCL_WQ07 (Abcam Jurkat NDUFS2 KO)
CVCL_WQ08 (Abcam Jurkat NFKBIA KO)CVCL_WQ09 (Abcam Jurkat NFKBIB KO)CVCL_WQ10 (Abcam Jurkat NMNAT1 KO)
CVCL_WQ11 (Abcam Jurkat NMT1 KO)CVCL_WQ12 (Abcam Jurkat NMT2 KO)CVCL_WQ13 (Abcam Jurkat NOD2 KO)
CVCL_WQ14 (Abcam Jurkat NOX5 KO)CVCL_WQ15 (Abcam Jurkat NPEPPS KO)CVCL_WQ16 (Abcam Jurkat NQO2 KO)
CVCL_WQ17 (Abcam Jurkat NUCB2 KO)CVCL_WQ18 (Abcam Jurkat OAT KO)CVCL_WQ19 (Abcam Jurkat OXSR1 KO)
CVCL_D1LE (Abcam Jurkat P3H1 KO)CVCL_D1LB (Abcam Jurkat PADI2 KO)CVCL_WQ20 (Abcam Jurkat PAICS KO)
CVCL_WQ21 (Abcam Jurkat PCMT1 KO)CVCL_WQ22 (Abcam Jurkat PCYT2 KO)CVCL_WQ23 (Abcam Jurkat PDHB KO)
CVCL_WQ24 (Abcam Jurkat PDHX KO)CVCL_WQ25 (Abcam Jurkat PEF1 KO)CVCL_WQ26 (Abcam Jurkat PGAM1 KO)
CVCL_WQ27 (Abcam Jurkat PGRMC1 KO)CVCL_WQ28 (Abcam Jurkat PI4KB KO)CVCL_WQ29 (Abcam Jurkat PIM2 KO)
CVCL_WQ30 (Abcam Jurkat PKLR KO)CVCL_WQ31 (Abcam Jurkat PLIN3 KO)CVCL_WQ32 (Abcam Jurkat PMVK KO)
CVCL_WQ33 (Abcam Jurkat PNMT KO)CVCL_WQ34 (Abcam Jurkat POLH KO)CVCL_WQ35 (Abcam Jurkat PPOX KO)
CVCL_WQ36 (Abcam Jurkat PPP2CB KO)CVCL_WQ37 (Abcam Jurkat PRDX5 KO)CVCL_D1LG (Abcam Jurkat PRG2 KO)
CVCL_WQ38 (Abcam Jurkat PRKAB1 KO)CVCL_WQ39 (Abcam Jurkat PRKACA KO)CVCL_WQ40 (Abcam Jurkat PRKAG1 KO)
CVCL_WQ41 (Abcam Jurkat PRKCG KO)CVCL_WQ42 (Abcam Jurkat PRKD1 KO)CVCL_D1LI (Abcam Jurkat PRSS8 KO)
CVCL_D1LH (Abcam Jurkat PSMF1 KO)CVCL_WQ43 (Abcam Jurkat PTPA KO)CVCL_B0Z8 (Abcam Jurkat PTPN2 KO)
CVCL_B7VF (Abcam Jurkat PVRIG KO)CVCL_WQ44 (Abcam Jurkat PYCR1 KO)CVCL_WQ45 (Abcam Jurkat QDPR KO)
CVCL_WQ46 (Abcam Jurkat RECQL KO)CVCL_WQ47 (Abcam Jurkat REEP5 KO)CVCL_WQ48 (Abcam Jurkat RPIA KO)
CVCL_WQ49 (Abcam Jurkat RXRB KO)CVCL_WQ50 (Abcam Jurkat SELENOP KO)CVCL_WQ51 (Abcam Jurkat SERPINB9 KO)
CVCL_WQ52 (Abcam Jurkat SH2D1A KO)CVCL_WQ53 (Abcam Jurkat SLAMF6 KO)CVCL_WQ54 (Abcam Jurkat SLC25A12 KO)
CVCL_WQ55 (Abcam Jurkat SLC5A1 KO)CVCL_WQ56 (Abcam Jurkat SLK KO)CVCL_D1LD (Abcam Jurkat SMS KO)
CVCL_WQ57 (Abcam Jurkat SORD KO)CVCL_WQ58 (Abcam Jurkat SPAG9 KO)CVCL_WQ59 (Abcam Jurkat SPTLC2 KO)
CVCL_WQ60 (Abcam Jurkat SRSF4 KO)CVCL_WQ61 (Abcam Jurkat SSTR2 KO)CVCL_WQ62 (Abcam Jurkat STK17B KO)
CVCL_WQ63 (Abcam Jurkat TACR1 KO)CVCL_B0Z9 (Abcam Jurkat TAL1 KO)CVCL_WQ64 (Abcam Jurkat TBL1XR1 KO)
CVCL_WQ65 (Abcam Jurkat TDP1 KO)CVCL_WQ66 (Abcam Jurkat TEC KO)CVCL_WQ67 (Abcam Jurkat THOP1 KO)
CVCL_WQ68 (Abcam Jurkat TLE3 KO)CVCL_WQ69 (Abcam Jurkat TNFSF9 KO)CVCL_B7VE (Abcam Jurkat TP53 KO)
CVCL_WQ70 (Abcam Jurkat TPD52 KO)CVCL_WQ71 (Abcam Jurkat TPMT KO)CVCL_WQ72 (Abcam Jurkat TPP1 KO)
CVCL_WQ73 (Abcam Jurkat TPP2 KO)CVCL_WQ74 (Abcam Jurkat TRPC3 KO)CVCL_D1LC (Abcam Jurkat TRPM2 KO)
CVCL_WQ75 (Abcam Jurkat UAP1 KO)CVCL_WQ76 (Abcam Jurkat UBE2T KO)CVCL_WQ77 (Abcam Jurkat UBR1 KO)
CVCL_WQ78 (Abcam Jurkat UNC119 KO)CVCL_WQ79 (Abcam Jurkat UPP1 KO)CVCL_WQ80 (Abcam Jurkat VDAC2 KO)
CVCL_WQ81 (Abcam Jurkat VPS37A KO)CVCL_WQ82 (Abcam Jurkat WAS KO)CVCL_WQ83 (Abcam Jurkat XPNPEP1 KO)
CVCL_B7VC (Abcam Jurkat ZAP70 KO)CVCL_U618 (BCL2 (AAA) Jurkat)CVCL_U619 (BCL2 (S70A) Jurkat)
CVCL_U620 (BCL2 (S87A) Jurkat)CVCL_U617 (BCL2 Jurkat)CVCL_C8ZJ (C11)
CVCL_KS58 (CellSensor CRE-bla Jurkat)CVCL_KS63 (CellSensor ISRE-bla Jurkat)CVCL_KB42 (CellSensor NFAT-bla Jurkat)
CVCL_KB43 (CellSensor NFkB-bla Jurkat)CVCL_U426 (Flp-In-Jurkat)CVCL_ZK91 (GeneBLAzer CMV-bla Jurkat)
CVCL_LB63 (GloResponse NFAT-RE-luc2 Jurkat)CVCL_2461 (H33HJ-JA1)CVCL_U324 (J-A1886)
CVCL_1H08 (J-Jhan)CVCL_8281 (J-Lat 10.6)CVCL_8282 (J-Lat 15.4)
CVCL_8280 (J-Lat 6.3)CVCL_8284 (J-Lat 8.4)CVCL_8285 (J-Lat 9.2)
CVCL_1H28 (J-Lat GFP Clone A72)CVCL_1G41 (J-Lat Tat-GFP Clone 82)CVCL_1G42 (J-Lat Tat-GFP Clone A1)
CVCL_1G43 (J-Lat Tat-GFP Clone A2)CVCL_1G44 (J-Lat Tat-GFP Clone A7)CVCL_1G45 (J-Lat Tat-GFP Clone H2)
CVCL_8279 (J1.1)CVCL_R861 (J14)CVCL_B7PR (JcTaxWT-Neo7)
CVCL_XF35 (JGFP1)CVCL_1Y74 (JinB8)CVCL_2966 (JKT-beta-del)
CVCL_XF44 (JSL1)CVCL_XF45 (JSL4)CVCL_IR10 (Jurkat 1G4)
CVCL_D5JP (Jurkat 2H4)CVCL_1061 (Jurkat clone A3)CVCL_3502 (Jurkat D1.1)
CVCL_0367 (Jurkat E6.1)CVCL_KU30 (Jurkat KZ142 clone #24)CVCL_XZ57 (Jurkat NF-kb luciferase reporter)
CVCL_YB71 (Jurkat pNFAT-EGFP)CVCL_EG05 (Jurkat R3.25)CVCL_C3G2 (Jurkat RB1-KO)
CVCL_KU38 (Jurkat Tet-Off)CVCL_KU35 (Jurkat Tet-On)CVCL_V356 (Jurkat Tet-On 3G)
CVCL_W813 (Jurkat tet-on clone 1)CVCL_W814 (Jurkat tet-on clone 2)CVCL_0584 (Jurkat Wurzburg)
CVCL_U326 (Jurkat-111)CVCL_1G47 (Jurkat-522 F/Y)CVCL_1G48 (Jurkat-7/3 STOP)
CVCL_6925 (Jurkat-77)CVCL_U323 (Jurkat-99)CVCL_X703 (Jurkat-A2)
CVCL_1G46 (Jurkat-deltaKS)CVCL_X593 (Jurkat-Dual)CVCL_JZ99 (Jurkat-F9-1906LUC)
CVCL_1F94 (Jurkat-HXBc2(4))CVCL_1F95 (Jurkat-HXBc2(6))CVCL_B332 (Jurkat-JMN)
CVCL_XX92 (Jurkat-LTRGT)CVCL_B7NZ (Jurkat-Luc-RFP)CVCL_KS47 (Jurkat-Lucia NFAT)
CVCL_C831 (Jurkat-TAg)CVCL_X692 (Jurkat-tat)CVCL_AR84 (Jurkat/A4)
CVCL_C9F1 (Jurkat/Cas9-hyg)CVCL_YJ84 (LINTERNA Jurkat)CVCL_L807 (MDS)
CVCL_8894 (MHH225)CVCL_U621 (Neo Jurkat)CVCL_KZ68 (PathHunter Jurkat IkappaB Degradation)
CVCL_1H23 (PPIA-/- Jurkat)CVCL_GY10 (UCDK9B1)CVCL_GY11 (UCDK9B2)
Sex of cell Male
Age at sampling 14Y
Category Cancer cell line
STR profile Source(s): CCRID=1101HUM-PUMC000347; COG; Cosmic-CLP=998184; DSMZ=ACC-282; ECACC=86010201; PubMed=28357668; RCB=RCB0537; RCB=RCB0806; TKG=TKG 0209

CSF1PO9,10,11 (RCB=RCB0537)
10,11 (Cosmic-CLP=998184; DSMZ=ACC-282)
10,12 (ECACC=86010201)
11 (RCB=RCB0806)
11,12 (CCRID=1101HUM-PUMC000347; COG; PubMed=28357668; TKG=TKG 0209)
D2S133819,23 (CCRID=1101HUM-PUMC000347; COG)
19,23,24 (DSMZ=ACC-282)
D3S135815 (CCRID=1101HUM-PUMC000347)
15,16,17 (COG; DSMZ=ACC-282)
15,17 (PubMed=28357668)
D7S8208,10 (CCRID=1101HUM-PUMC000347; COG; ECACC=86010201; RCB=RCB0537; TKG=TKG 0209)
8,10,11 (Cosmic-CLP=998184; DSMZ=ACC-282; RCB=RCB0806)
8,12 (PubMed=28357668)
D8S117912,14,15 (COG)
13 (DSMZ=ACC-282)
13,14 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
D13S3178,10,11 (TKG=TKG 0209)
8,11 (COG; Cosmic-CLP=998184; DSMZ=ACC-282; ECACC=86010201; RCB=RCB0537)
8,11,12 (RCB=RCB0806)
8,12 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
D16S53910,11 (ECACC=86010201; RCB=RCB0537)
11 (CCRID=1101HUM-PUMC000347; COG; Cosmic-CLP=998184; DSMZ=ACC-282; PubMed=28357668; RCB=RCB0806; TKG=TKG 0209)
D18S5113,14,20,21 (DSMZ=ACC-282)
13,21 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
D19S43313,15.2 (COG; PubMed=28357668)
13,16 (DSMZ=ACC-282)
14,15.2 (CCRID=1101HUM-PUMC000347)
D21S1131.2,32.2 (COG)
31.2,33.2 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
31.2,32.2,33.2 (DSMZ=ACC-282)
FGA20,21 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
20,21,22 (DSMZ=ACC-282)
20,22 (COG)
Penta D11,13
Penta E9,10,12 (DSMZ=ACC-282)
10,12 (PubMed=28357668)
TPOX8,9,10 (RCB=RCB0537)
8,10 (CCRID=1101HUM-PUMC000347; COG; Cosmic-CLP=998184; DSMZ=ACC-282; ECACC=86010201; PubMed=28357668; RCB=RCB0806; TKG=TKG 0209)
vWA16,17,18 (RCB=RCB0537; RCB=RCB0806)
16,17,19,20 (ECACC=86010201)
17,18,19 (COG)
17,18,19,20 (DSMZ=ACC-282)
18 (CCRID=1101HUM-PUMC000347; PubMed=28357668)
18,19,20 (Cosmic-CLP=998184)
18,20 (TKG=TKG 0209)

Run an STR similarity search on this cell line
Web pages https://en.wikipedia.org/wiki/Jurkat_cells

PubMed=1103999; DOI=10.1007/BF01634146
Schwenk H.-U., Schneider U.
Cell cycle dependency of a T-cell marker on lymphoblasts.
Blut 31:299-306(1975)

Kaplan J., Peterson W.D. Jr.
Detection of T-cell lymphoma-associated antigens on cord blood lymphocytes and phytohemagglutinin-stimulated blasts.
Cancer Res. 36:3471-3475(1976)

PubMed=68013; DOI=10.1002/ijc.2910190505
Schneider U., Schwenk H.-U., Bornkamm G.-W.
Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma.
Int. J. Cancer 19:621-626(1977)

PubMed=204546; DOI=10.1007/978-3-642-66639-1_32
Schneider U., Schwenk H.-U.
Characterization of 'T' and 'non-T' cell lines established from children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after leukemic transformation.
Haematol. Blood Transfus. 20:265-269(1977)

PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0
Drexler H.G., Gaedicke G., Minowada J.
Isoenzyme studies in human leukemia-lymphoma cell lines -- 1 carboxylic esterase.
Leuk. Res. 9:209-229(1985)

PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1
Drexler H.G., Gaedicke G., Minowada J.
Isoenzyme studies in human leukemia-lymphoma cell lines -- III Beta-hexosaminidase (E.C.
Leuk. Res. 9:549-559(1985)

PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x
Drexler H.G., Gaedicke G., Minowada J.
Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid phosphatase.
Leuk. Res. 9:537-548(1985)

LaGree K.A., Lee A.T., Stetten G., Strauss P.R.
The human Jurkat (FHCRC-11) cell line is heterogeneous in ploidy and cell size and releases detergent-soluble DNA.
Exp. Hematol. 16:686-690(1988)

PubMed=2144611; DOI=10.1128/mcb.10.10.5502-5509.1990
Cheng J., Haas M.
Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
Mol. Cell. Biol. 10:5502-5509(1990)

PubMed=1915666; DOI=10.1016/0014-4827(91)90482-A
Limouse M., Manie S., Konstantinova I., Ferrua B., Schaffar L.
Inhibition of phorbol ester-induced cell activation in microgravity.
Exp. Cell Res. 197:82-86(1991)

Heyman M., Grander D., Brondum-Nielsen K., Cederblad B., Liu Y., Xu B., Einhorn S.
Interferon system defects in malignant T-cells.
Leukemia 8:425-434(1994)

PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x
Siebert R., Willers C.P., Schramm A., Fossa A., Dresen I.M.G., Uppenkamp M., Nowrousian M.R., Seeber S., Opalka B.
Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines.
Br. J. Haematol. 91:350-354(1995)

Morita S., Tsuchiya S., Fujie H., Itano M., Ohashi Y., Minegishi M., Imaizumi M., Endo M., Takano N., Konno T.
Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture.
Leukemia 10:102-105(1996)

PubMed=8641406; DOI=10.1111/j.1600-0609.1996.tb00721.x
Borgonovo-Brandter L., Heyman M., Rasool O., Liu Y., Grander D., Einhorn S.
p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines.
Eur. J. Haematol. 56:313-318(1996)

PubMed=8957066; DOI=10.1111/j.1349-7006.1996.tb03112.x
Kawasaki N., Matsuo Y., Yoshino T., Yanai H., Oka T., Teramoto N., Liu C., Kondo E., Minowada J., Akagi T.
Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44.
Jpn. J. Cancer Res. 87:1070-1077(1996)

PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x
Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y., Hirai H.
Frameshift mutations of the hMSH6 gene in human leukemia cell lines.
Jpn. J. Cancer Res. 89:33-39(1998)

PubMed=9583678; DOI=10.1038/sj.onc.1201704
Brimmell M., Mendiola R., Mangion J., Packham G.
BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability.
Oncogene 16:1803-1812(1998)

PubMed=9685479; DOI=10.1093/nar/26.16.3651
Hultdin M., Gronlund E., Norrback K.-F., Eriksson-Lindstrom E., Just T., Roos G.
Telomere analysis by fluorescence in situ hybridization and flow cytometry.
Nucleic Acids Res. 26:3651-3656(1998)

PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x
Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T., Aizawa Y., Ueda R., Seto M.
Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.
Jpn. J. Cancer Res. 89:712-718(1998)

PubMed=9787181; DOI=10.1182/blood.V92.9.3410
Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., Raffeld M.
PTEN gene alterations in lymphoid neoplasms.
Blood 92:3410-3415(1998)

PubMed=9933131; DOI=10.1016/S0145-2126(98)00133-7
Burger R., Hansen-Hagge T.E., Drexler H.G., Gramatzki M.
Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies.
Leuk. Res. 23:19-27(1999)

PubMed=10071127; DOI=10.1016/S0145-2126(98)00146-5
Kawamura M., Ohnishi H., Guo S.-X., Sheng X.-M., Minegishi M., Hanada R., Horibe K., Hongo T., Kaneko Y., Bessho F., Yanagisawa M., Sekiya T., Hayashi Y.
Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
Leuk. Res. 23:115-126(1999)

PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4
Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.
Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines.
Leuk. Res. 24:255-262(2000)

PubMed=11021758; DOI=10.1038/sj.leu.2401891
Majka M., Rozmyslowicz T., Honczarenko M., Ratajczak J., Wasik M.A., Gaulton G.N., Ratajczak M.Z.
Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines.
Leukemia 14:1821-1832(2000)

Drexler H.G.
The leukemia-lymphoma cell line factsbook.
(In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001)

PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1
Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.
Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24 (2000),255-262.
Leuk. Res. 25:275-278(2001)

PubMed=15028022; DOI=10.1111/j.1440-1827.2004.01612.x
Kamimura K., Hojo H., Abe M.
Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: relationship between its expression and prognosis.
Pathol. Int. 54:224-230(2004)

PubMed=15472075; DOI=10.1126/science.1102160
Weng A.P., Ferrando A.A., Lee W., Morris J.P. IV, Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C.
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
Science 306:269-271(2004)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=17117183; DOI=10.1038/sj.bjc.6603447
Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J., Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.
Br. J. Cancer 95:1537-1544(2006)

PubMed=17170727; DOI=10.1038/sj.leu.2404486
Sandberg Y., Verhaaf B., van Gastel-Mol E.J., Wolvers-Tettero I.L.M., De Vos J., MacLeod R.A.F., Noordzij J.G., Dik W.A., van Dongen J.J.M., Langerak A.W.
Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes.
Leukemia 21:230-237(2007)

PubMed=19220422; DOI=10.1111/j.1600-0609.2009.01211.x
Kamihira S., Terada C., Sasaki D., Yanagihara K., Tsukasaki K., Hasegawa H., Yamada Y.
Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.
Eur. J. Haematol. 82:301-307(2009)

PubMed=19473701; DOI=10.1016/j.leukres.2009.04.032
Lo T.C.T., Barnhill L.M., Kim Y., Nakae E.A., Yu A.L.-T., Diccianni M.B.
Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing.
Leuk. Res. 33:1562-1566(2009)

PubMed=19608861; DOI=10.1126/science.1175371
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.
Lysine acetylation targets protein complexes and co-regulates major cellular functions.
Science 325:834-840(2009)

PubMed=22278370; DOI=10.1074/mcp.M111.014050
Geiger T., Wehner A., Schaab C., Cox J., Mann M.
Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins.
Mol. Cell. Proteomics 11:M111.014050-M111.014050(2012)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=22675565; DOI=10.1371/journal.pone.0038463
Atak Z.K., De Keersmaecker K., Gianfelici V., Geerdens E., Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G., Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P., Cools J., Aerts S.
High accuracy mutation detection in leukemia on a selected panel of cancer genes.
PLoS ONE 7:E38463-E38463(2012)

PubMed=22944676; DOI=10.1515/hsz-2012-0195
Reinke S.O., Bayer M., Berger M., Hinderlich S., Blanchard V.
The analysis of N-glycans of cell membrane proteins from human hematopoietic cell lines reveals distinctions in their pattern.
Biol. Chem. 393:731-747(2012)

PubMed=23325432; DOI=10.1101/gr.147942.112
Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., Absher D.M., Wold B.J., Myers R.M.
Dynamic DNA methylation across diverse human cell lines and tissues.
Genome Res. 23:555-567(2013)

PubMed=24618588; DOI=10.1371/journal.pone.0091433
Chernobrovkin A.L., Zubarev R.A.
Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins.
PLoS ONE 9:E91433-E91433(2014)

PubMed=26074081; DOI=10.1016/j.celrep.2015.05.029
Giansanti P., Aye T.T., van den Toorn H., Peng M., van Breukelen B., Heck A.J.R.
An augmented multiple-protease-based human phosphopeptide atlas.
Cell Rep. 11:1834-1843(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

PubMed=28357668; DOI=10.1007/978-1-4939-6872-5_11
Raimondi V., Minuzzo S.A., Ciminale V., D'Agostino D.M.
STR profiling of HTLV-1-infected cell lines.
Methods Mol. Biol. 1582:143-154(2017)

PubMed=29967540; DOI=10.1038/s41594-018-0084-y
Akimov V., Barrio-Hernandez I., Hansen S.V.F., Hallenborg P., Pedersen A.-K., Bekker-Jensen D.B., Puglia M., Christensen S.D.K., Vanselow J.T., Nielsen M.M., Kratchmarova I., Kelstrup C.D., Olsen J.V., Blagoev B.
UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites.
Nat. Struct. Mol. Biol. 25:631-640(2018)

PubMed=30285677; DOI=10.1186/s12885-018-4840-5
Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H., Koeffler H.P.
Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines.
BMC Cancer 18:940.1-940.13(2018)

PubMed=30629668; DOI=10.1371/journal.pone.0210404
Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G.
Screening human cell lines for viral infections applying RNA-Seq data analysis.
PLoS ONE 14:E0210404-E0210404(2019)

PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001
Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R., Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K., Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A., Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M., Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R., Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H., Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F., Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A., Fernandez-Vina M.A.
Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: report from the 17th International HLA and Immunogenetics Workshop.
Hum. Immunol. 80:449-460(2019)

PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Cancer Res. 79:1263-1273(2019)

PubMed=31068700; DOI=10.1038/s41586-019-1186-3
Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R.
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature 569:503-508(2019)

PubMed=31160637; DOI=10.1038/s41598-019-44491-x
Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K., Uphoff C.C., Drexler H.G.
The LL-100 panel: 100 cell lines for blood cancer studies.
Sci. Rep. 9:8218-8218(2019)

PubMed=31978347; DOI=10.1016/j.cell.2019.12.023
Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E.T., Schweppe D.K., Jedrychowski M.P., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P.
Quantitative proteomics of the Cancer Cell Line Encyclopedia.
Cell 180:387-402.e16(2020)

PubMed=35354797; DOI=10.1038/s41467-022-29224-5
Leo I.R., Aswad L., Stahl M., Kunold E., Post F., Erkers T., Struyf N., Mermelekas G., Joshi R.N., Gracia-Villacampa E., Ostling P., Kallioniemi O.-P., Pokrovskaja Tamm K., Siavelis I., Lehtio J., Vesterlund M., Jafari R.
Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines.
Nat. Commun. 13:1691.1-1691.19(2022)

PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010
Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Pan-cancer proteomic map of 949 human cell lines.
Cancer Cell 40:835-849.e8(2022)

Cell line collections (Providers) Abcam; ab271143
Abcam; ab275468
CLS; 302147
CLS; 305018 - Discontinued
ECACC; 86010201
HIVReagentProgram; ARP-4668
IBRC; C10155
ICLC; HTL01002 - Discontinued
KCB; KCB 94018YJ
NCBI_Iran; C120
RCB; RCB0537
RCB; RCB0806
RCB; RCB3052
TKG; TKG 0209
Cell line databases/resources CLO; CLO_0007029
CLO; CLO_0007043
CLO; CLO_0050978
CLO; CLO_0050993
CLO; CLO_0051001
MCCL; MCC:0000503
CLDB; cl2950
CLDB; cl2959
CLDB; cl2960
CLDB; cl2961
CLDB; cl5212
cancercelllines; CVCL_0065
CCRID; 1101HUM-PUMC000347
Cell_Model_Passport; SIDM01016
Cosmic-CLP; 998184
DepMap; ACH-000995
DSMZCellDive; ACC-282
IHW; IHW00002
Lonza; 142
TOKU-E; 3710
Anatomy/cell type resources BTO; BTO:0000661
Biological sample resources BioSample; SAMN03472181
BioSample; SAMN03472286
BioSample; SAMN03473341
BioSample; SAMN10988565
CRISP screens repositories BioGRID_ORCS_Cell_line; 1255
Chemistry resources ChEMBL-Cells; CHEMBL3307526
ChEMBL-Targets; CHEMBL397
GDSC; 998184
PharmacoDB; JURKAT_712_2019
PubChem_Cell_line; CVCL_0065
Encyclopedic resources Wikidata; Q1632589
Experimental variables resources EFO; EFO_0002796
Gene expression databases ArrayExpress; E-MTAB-2770
ArrayExpress; E-MTAB-3610
ArrayExpress; E-MTAB-7721
ArrayExpress; E-MTAB-7722
GEO; GSM1991
GEO; GSM236783
GEO; GSM236819
GEO; GSM482494
GEO; GSM749672
GEO; GSM887188
GEO; GSM888261
GEO; GSM1040307
GEO; GSM1040377
GEO; GSM1374580
GEO; GSM1669965
GEO; GSM5137718
GEO; GSM5534218
GEO; GSM5534219
GEO; GSM5534220
GEO; GSM5534221
GEO; GSM5534222
GEO; GSM5534223
Medical resources MeSH; D019169
Polymorphism and mutation databases Cosmic; 683539
Cosmic; 721707
Cosmic; 755289
Cosmic; 801727
Cosmic; 850196
Cosmic; 913426
Cosmic; 919152
Cosmic; 922675
Cosmic; 933540
Cosmic; 991544
Cosmic; 998737
Cosmic; 999757
Cosmic; 1012072
Cosmic; 1037693
Cosmic; 1115592
Cosmic; 1118463
Cosmic; 1118464
Cosmic; 1127262
Cosmic; 1130236
Cosmic; 1132774
Cosmic; 1175129
Cosmic; 1191689
Cosmic; 1224368
Cosmic; 1226860
Cosmic; 1330489
Cosmic; 1375588
Cosmic; 1483364
Cosmic; 1524798
Cosmic; 1639637
Cosmic; 1641380
Cosmic; 1664522
Cosmic; 1760524
Cosmic; 1811157
Cosmic; 2039520
Cosmic; 2165713
Cosmic; 2301569
Cosmic; 2361366
Cosmic; 2602916
Cosmic; 2750872
IARC_TP53; 186
LiGeA; CCLE_029
Progenetix; CVCL_0065
Proteomic databases PRIDE; PRD000008
PRIDE; PRD000013
PRIDE; PXD000443
PRIDE; PRD000787
PRIDE; PXD000426
PRIDE; PXD001428
PRIDE; PXD001872
PRIDE; PXD002091
PRIDE; PXD002395
PRIDE; PXD006201
PRIDE; PXD023662
PRIDE; PXD030304
Sequence databases EGA; EGAS00001000978
EGA; EGAS00001002554
Entry history
Entry creation04-Apr-2012
Last entry update02-May-2024
Version number45